COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 95 filers reported holding COHERUS BIOSCIENCES INC in Q3 2017. The put-call ratio across all filers is 0.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $207,649 | +13.9% | 55,521 | +30.1% | 0.00% | 0.0% |
Q2 2023 | $182,273 | +63409.8% | 42,687 | +1.6% | 0.00% | -50.0% |
Q1 2023 | $287 | -1.7% | 42,004 | +14.1% | 0.00% | -33.3% |
Q4 2022 | $292 | -99.9% | 36,828 | +56.0% | 0.01% | +20.0% |
Q3 2022 | $227,000 | -82.1% | 23,610 | -86.5% | 0.01% | -84.8% |
Q2 2022 | $1,268,000 | -47.9% | 175,090 | -7.2% | 0.03% | -42.1% |
Q1 2022 | $2,436,000 | -22.2% | 188,701 | -3.8% | 0.06% | +9.6% |
Q4 2021 | $3,132,000 | +954.5% | 196,222 | +1089.9% | 0.05% | +300.0% |
Q4 2019 | $297,000 | -29.3% | 16,491 | -46.5% | 0.01% | -23.5% |
Q1 2019 | $420,000 | +61.5% | 30,809 | +58.0% | 0.02% | +142.9% |
Q3 2017 | $260,000 | -36.9% | 19,502 | -32.0% | 0.01% | -46.2% |
Q2 2017 | $412,000 | -16.1% | 28,681 | +23.5% | 0.01% | -13.3% |
Q1 2017 | $491,000 | +21.2% | 23,223 | +61.3% | 0.02% | +50.0% |
Q4 2016 | $405,000 | +41.6% | 14,396 | +34.9% | 0.01% | +42.9% |
Q3 2016 | $286,000 | +49.7% | 10,670 | -5.6% | 0.01% | +75.0% |
Q2 2016 | $191,000 | – | 11,300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |